Frontiers in Oncology (Feb 2022)
Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors
- Paul Takam Kamga,
- Aurélie Swalduz,
- Aurélie Swalduz,
- Adrien Costantini,
- Adrien Costantini,
- Catherine Julié,
- Catherine Julié,
- Jean-François Emile,
- Maurice Pérol,
- Virginie Avrillon,
- Sandra Ortiz-Cuaran,
- Pierre De Saintigny,
- Pierre De Saintigny,
- Etienne Giroux-Leprieur,
- Etienne Giroux-Leprieur
Affiliations
- Paul Takam Kamga
- Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France
- Aurélie Swalduz
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France
- Aurélie Swalduz
- Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France
- Adrien Costantini
- Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France
- Adrien Costantini
- Department of Respiratory Diseases and Thoracic Oncology, APHP – Hopital Ambroise Pare, Boulogne-Billancourt, France
- Catherine Julié
- Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France
- Catherine Julié
- Department of Pathology, APHP – Hopital Ambroise Pare, Boulogne-Billancourt, France
- Jean-François Emile
- Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France
- Maurice Pérol
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France
- Virginie Avrillon
- Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France
- Sandra Ortiz-Cuaran
- Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France
- Pierre De Saintigny
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France
- Pierre De Saintigny
- Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France
- Etienne Giroux-Leprieur
- Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France
- Etienne Giroux-Leprieur
- Department of Respiratory Diseases and Thoracic Oncology, APHP – Hopital Ambroise Pare, Boulogne-Billancourt, France
- DOI
- https://doi.org/10.3389/fonc.2022.852540
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- non-small cell lung cancer (NSCLC)
- epidermal growth factor receptor (EGFR)
- Sonic Hedgehog (Shh)
- biomarker
- tyrosine kinase inhibitor (TKI)
